These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6420721

  • 1. Alteration of morphine withdrawal to naloxone by interferon.
    Dafny N, Zielinksi M, Reyes-Vazquez C.
    Neuropeptides; 1983 Oct; 3(6):453-63. PubMed ID: 6420721
    [Abstract] [Full Text] [Related]

  • 2. Interferon as an endocoids candidate preventing and attenuating opiate addiction.
    Dafny N.
    Prog Clin Biol Res; 1985 Oct; 192():269-76. PubMed ID: 4080713
    [Abstract] [Full Text] [Related]

  • 3. Three different types of alpha-interferons alter naloxone-induced abstinence in morphine-addicted rats.
    Dafny N, Reyes-Vazquez C.
    Immunopharmacology; 1985 Feb; 9(1):13-7. PubMed ID: 4039302
    [Abstract] [Full Text] [Related]

  • 4. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
    Cox B, Ary M, Lomax P.
    J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
    [Abstract] [Full Text] [Related]

  • 5. Auricular microelectrostimulation: naloxone-reversible attenuation of opiate abstinence syndrome.
    Malin DH, Murray JB, Crucian GP, Schweitzer FC, Cook RE, Skolnick MH.
    Biol Psychiatry; 1988 Dec; 24(8):886-90. PubMed ID: 2852967
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential expression of response-disruptive and somatic indices of opiate withdrawal during the initiation and development of opiate dependence.
    Schulteis G, Heyser CJ, Koob GF.
    Behav Pharmacol; 1999 May; 10(3):235-42. PubMed ID: 10780239
    [Abstract] [Full Text] [Related]

  • 9. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats.
    Maldonado R, Girdlestone D, Roques BP.
    Neurosci Lett; 1993 Jun 25; 156(1-2):135-40. PubMed ID: 7692360
    [Abstract] [Full Text] [Related]

  • 10. Chronic treatment with ascorbic acid inhibits the morphine withdrawal response in guinea-pigs.
    Johnston PA, Chahl LA.
    Neurosci Lett; 1992 Jan 20; 135(1):23-7. PubMed ID: 1542433
    [Abstract] [Full Text] [Related]

  • 11. Single injection of three different preparations of alpha-interferon modifies morphine abstinence signs for a prolonged period.
    Dafny N, Reyes-Vazquez C.
    Int J Neurosci; 1987 Feb 20; 32(3-4):953-61. PubMed ID: 3596938
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporine alters opiate withdrawal in rodents.
    Dafny N, Wagle VG, Drath DB.
    Life Sci; 1985 May 06; 36(18):1721-6. PubMed ID: 4039025
    [Abstract] [Full Text] [Related]

  • 13. Interferon modifies morphine withdrawal phenomena in rodents.
    Dafny N.
    Neuropharmacology; 1983 May 06; 22(5):647-51. PubMed ID: 6192350
    [Abstract] [Full Text] [Related]

  • 14. Modification of morphine withdrawal by interferon.
    Dafny N.
    Life Sci; 1983 Jan 24; 32(4):303-5. PubMed ID: 6681856
    [No Abstract] [Full Text] [Related]

  • 15. [Different roles of the spinal protein kinase C alpha and gamma in morphine dependence and naloxone-precipitated withdrawal].
    Cao JL, Ding HL, He JH, Zhang LC, Wang JK, Zeng YM.
    Sheng Li Xue Bao; 2005 Apr 25; 57(2):161-8. PubMed ID: 15830100
    [Abstract] [Full Text] [Related]

  • 16. Rapid induction and quantitation of morphine dependence in the rat by pellet implantation.
    Bhargava HN.
    Psychopharmacology (Berl); 1977 Mar 23; 52(1):55-62. PubMed ID: 403558
    [Abstract] [Full Text] [Related]

  • 17. The effects of orally active enkephalinase inhibitors on morphine withdrawal syndrome.
    Dzoljic MR, Bokszanska A, Korenhof AM, Kaplan CD, Dzoljic M, Rupreht J, Zijlstra FJ, Brinkman EC, Cappendijk SL.
    Neuroreport; 1992 Jul 23; 3(7):637-40. PubMed ID: 1421123
    [Abstract] [Full Text] [Related]

  • 18. On the role of striatal and nonstriatal dopamine in opiate withdrawal.
    Herz A, Bläsig J, Laschka E, Gramsch C.
    Adv Biochem Psychopharmacol; 1977 Jul 23; 16():597-9. PubMed ID: 560794
    [No Abstract] [Full Text] [Related]

  • 19. Enkephalinase inhibitors attenuate naloxone-precipitated withdrawal syndrome.
    Dzoljic MR.
    NIDA Res Monogr; 1986 Jul 23; 75():575-8. PubMed ID: 3123978
    [Abstract] [Full Text] [Related]

  • 20. Dopaminergic-cholinergic interactions in naloxone-induced circling in morphine-dependent rats with nigral lesions.
    Iwamoto ET, Loh HH, Way EL.
    Eur J Pharmacol; 1976 Jul 23; 38(1):39-54. PubMed ID: 986306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.